Yuming G.

Senior Director of Pharmacology and Toxicology @ Biocytogen

Country

China

City

Beijing

Industry

Pharmaceuticals

Skill

siRNA, Small molecule, Antibody, Hyperlipidemia, Thrombosis, pre-clinical PK-PD, Toxicology, Non-clinical, IND-enabling, Immunology, Cancer Biology, Translational Research, cancer stem cells biology, Mechanism Discovery

Experience

Senior Director of Pharmacology and Toxicology

Biocytogen

2021-12 - Present · 4 yrs 10 mos

中国北京市

Senior Director of Pharmacology&Toxicology&Bioanalysis，preclinical develop of innovative antibody drugs，as well as bio-analysis of clinical pharmacology part.

Director of Pharmacology，Preclinical-Projects leader

Suzhou Ribo Life Science Co., Ltd (Ribolia)

2021-2 - 2021-12 · 11 mos

Leader of preclinical projects & Director of Pharmacology with 30 personnel team

Director of Pharmacology，Preclinical-Projects leader

Sichuan Kelun Pharmaceutical Co., Ltd.

2019-2 - 2021-2 · 2 yrs 1 mo

1、Innovative drugs (Small&Big Molecules)candidates screening，validation, and IND-enabling studies at pharmacological platforms ; 2、PCC-IND Projects leaders for Oncology and non-Oncology across multiple functions including pharmacology, toxicity and PKPD.

Director～VP of pharmacology

Shenogen Pharma Group Ltd.

2010-7 - 2019-1 · 8 yrs 7 mos

Beijing

First in class drugs: Candidates screening, validating and IND-enabling study at the pharmacological in vivo and in vitro platforms. Biomarkers investigation and preclinical combination studies. Cancer stem cells and immune oncology platform development (Cancer immunology, Cancer immunotherapy, Cancer stem cells, Target, Signalling Cancer translational reseach Animals, Cells and Molecular Platforms In house & CRO projects. )